OXTR and breast cancer: In addition, it is important to acquire a more comprehensive understanding of the physiological and pathological consequences of both G protein-dependent and β-arrestin-dependent signalling (including β-arrestin-1 and -2 pathways), particularly when it comes to targeting OTR in breast cancer.